CDT Equity Inc. to Invest $115M for 20% Stake in Sarborg AI
CDT Equity Inc. will acquire a 20% stake in AI firm Sarborg Limited for $115 million, issuing 598,005 common shares and 109,978,918 pre-funded warrants plus an $8 million deferred payment. The deal deepens CDT’s collaboration to leverage Sarborg’s AI-driven signature intelligence and chemistry, expanding its asset development platform beyond pharmaceuticals.
1. Transaction Details
CDT Equity Inc. will acquire a 20% equity stake in agentic AI firm Sarborg Limited for a total consideration of $115,000,000, issued via 598,005 newly issued common shares and 109,978,918 pre-funded warrants, with an additional $8,000,000 deferred payment payable upon completion of future fundraising.
2. Strategic Alignment
The transaction formalizes CDT’s existing collaboration with Sarborg to leverage proprietary AI-driven signature intelligence and chemistry capabilities, creating scientific and commercial synergies across pharmaceuticals and multiple industrial sectors and broadening CDT’s exposure to data-driven asset development beyond its core biopharmaceutical portfolio.
3. Approval and Impact
Shareholder approval is required for the issuance of shares and warrants, with the transaction expected to enhance CDT’s strategic flexibility and growth profile by providing equity exposure to Sarborg’s expanding operations, potentially affecting future asset valuations and diluting share count.